Evolent Health, Inc. Class A(EVH US)
$4.90+0.132.73%
- Pricing and plans
Get the full experience
We save the real magic for signed-in users.
Get the full experience
We save the real magic for signed-in users.
Get the full experience
We save the real magic for signed-in users.
| Millions USD (ex. Per Share) | FY201212/31/2012 | FY201312/31/2013 | FY201412/31/2014 | FY201512/31/2015 | FY201612/31/2016 | FY201712/31/2017 | FY201812/31/2018 | FY201912/31/2019 | FY202012/31/2020 | FY202112/31/2021 | FY202212/31/2022 | FY202312/31/2023 | FY202412/31/2024 | FY202512/31/2025 | Last 12M03/31/2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,963.9 | 2,554.7 | 1,876.2 | 1,888.8 | |||||||||||||
| -Cost of Revenue | 1,503.4 | 2,187.4 | 1,592.2 | 1,621.9 | |||||||||||||
| Gross Profit | 460.5 | 367.4 | 284.0 | 266.9 | |||||||||||||
| -Operating Expenses | 531.7 | 407.8 | 288.5 | 283.2 | |||||||||||||
| +Selling, General & Admin | 358.1 | 263.1 | 288.5 | 283.2 | |||||||||||||
| +General And Administrative Expenses | - | - | - | — | |||||||||||||
| +Selling And Marketing Expenses | - | - | - | — | |||||||||||||
| +Research and Development | - | - | - | - | |||||||||||||
| +Other Operating Expenses | 173.6 | 144.8 | - | - | |||||||||||||
| Operating Income | -71.2 | -40.5 | -4.4 | -16.3 | |||||||||||||
| +Non Operating Income | -180.1 | -41.7 | -583.5 | -540.9 | |||||||||||||
| +Interest Income, Net | -48.9 | -19.2 | -53.3 | -60.0 | |||||||||||||
| +Interest Income | 5.3 | 5.5 | 4.2 | 3.9 | |||||||||||||
| -Interest Expense | 54.2 | 24.7 | 57.5 | 64.0 | |||||||||||||
| +Other Non-Op Income | -131.2 | -22.6 | -530.2 | -480.9 | |||||||||||||
| Pretax Income | -202.4 | -63.0 | -534.6 | -497.2 | |||||||||||||
| -Income Tax Expense | -89.4 | -1.4 | -0.1 | -0.7 | |||||||||||||
| Income from Cont Ops | -113.0 | -61.6 | -534.5 | -496.5 | |||||||||||||
| -Net Extraordinary Losses | - | - | - | - | |||||||||||||
| +Discounted operations | - | - | - | - | |||||||||||||
| +XO & Accounting Changes | - | - | - | - | |||||||||||||
| Income Incl. MI | -113.0 | -61.6 | -534.5 | -496.5 | |||||||||||||
| -Minority Interests | - | - | 0.0 | - | |||||||||||||
| Net Income, GAAP | -113.0 | -61.6 | -534.5 | -496.5 | |||||||||||||
| -Prfrrd Div & Other | - | - | - | - | |||||||||||||
| Net Income Avail To Common | -142.3 | -93.5 | -579.4 | -533.8 | |||||||||||||
| Weighted Average Shs Out | 111,251,000 | 114,682,000 | 114,208,000 | 456,061,000 | |||||||||||||
| EPS | -1.3 | -0.8 | -5.1 | -4.7 | |||||||||||||
| Weighted Average Shs Out Dil | 111,251,000 | 114,682,000 | 114,208,000 | 456,061,000 | |||||||||||||
| EPS Diluted | -1.3 | -0.8 | -5.1 | -4.7 | |||||||||||||
| Millions USD (ex. Per Share) | FY201212/31/2012 | FY201312/31/2013 | FY201412/31/2014 | FY201512/31/2015 | FY201612/31/2016 | FY201712/31/2017 | FY201812/31/2018 | FY201912/31/2019 | FY202012/31/2020 | FY202112/31/2021 | FY202212/31/2022 | FY202312/31/2023 | FY202412/31/2024 | FY202512/31/2025 | Last 12M03/31/2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,963.9 | 2,554.7 | 1,876.2 | 1,888.8 | |||||||||||||
| -Cost of Revenue | 1,503.4 | 2,187.4 | 1,592.2 | 1,621.9 | |||||||||||||
| Gross Profit | 460.5 | 367.4 | 284.0 | 266.9 | |||||||||||||
| -Operating Expenses | 531.7 | 407.8 | 288.5 | 283.2 | |||||||||||||
| +Selling, General & Admin | 358.1 | 263.1 | 288.5 | 283.2 | |||||||||||||
| +General And Administrative Expenses | - | - | - | — | |||||||||||||
| +Selling And Marketing Expenses | - | - | - | — | |||||||||||||
| +Research and Development | - | - | - | - | |||||||||||||
| +Other Operating Expenses | 173.6 | 144.8 | - | - | |||||||||||||
| Operating Income | -71.2 | -40.5 | -4.4 | -16.3 | |||||||||||||
| +Non Operating Income | -180.1 | -41.7 | -583.5 | -540.9 | |||||||||||||
| +Interest Income, Net | -48.9 | -19.2 | -53.3 | -60.0 | |||||||||||||
| +Interest Income | 5.3 | 5.5 | 4.2 | 3.9 | |||||||||||||
| -Interest Expense | 54.2 | 24.7 | 57.5 | 64.0 | |||||||||||||
| +Other Non-Op Income | -131.2 | -22.6 | -530.2 | -480.9 | |||||||||||||
| Pretax Income | -202.4 | -63.0 | -534.6 | -497.2 | |||||||||||||
| -Income Tax Expense | -89.4 | -1.4 | -0.1 | -0.7 | |||||||||||||
| Income from Cont Ops | -113.0 | -61.6 | -534.5 | -496.5 | |||||||||||||
| -Net Extraordinary Losses | - | - | - | - | |||||||||||||
| +Discounted operations | - | - | - | - | |||||||||||||
| +XO & Accounting Changes | - | - | - | - | |||||||||||||
| Income Incl. MI | -113.0 | -61.6 | -534.5 | -496.5 | |||||||||||||
| -Minority Interests | - | - | 0.0 | - | |||||||||||||
| Net Income, GAAP | -113.0 | -61.6 | -534.5 | -496.5 | |||||||||||||
| -Prfrrd Div & Other | - | - | - | - | |||||||||||||
| Net Income Avail To Common | -142.3 | -93.5 | -579.4 | -533.8 | |||||||||||||
| Weighted Average Shs Out | 111,251,000 | 114,682,000 | 114,208,000 | 456,061,000 | |||||||||||||
| EPS | -1.3 | -0.8 | -5.1 | -4.7 | |||||||||||||
| Weighted Average Shs Out Dil | 111,251,000 | 114,682,000 | 114,208,000 | 456,061,000 | |||||||||||||
| EPS Diluted | -1.3 | -0.8 | -5.1 | -4.7 | |||||||||||||